Shilpa Thakur

Employment

• National Institutes of Health Research fellow
  2020 - Present
• National Institutes of Health Postdoctoral fellow
  2016 - 2020
• The University of Iowa Postdoctoral fellow
  2015 - 2016

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (51)

• Supplementary Figure 6 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479876.v1
  +Save
• Data from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.c.6530313.v1
  +Save
• Supplementary table 3 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479861
  +Save
• Supplementary table 3 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479861.v1
  +Save
• Supplementary table 2 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479864
  +Save
• Supplementary table 2 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479864.v1
  +Save
• Supplementary table 1 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479867
  +Save
• Supplementary table 1 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479867.v1
  +Save
• Supplementary Figure 8 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479870
  +Save
• Supplementary Figure 8 from 177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
  2023 0 citations DOI: 10.1158/1078-0432.22479870.v1
  +Save